Literature DB >> 23988813

Second transurethral resection after Ta high-grade bladder tumor: a 4.5-year period at a single university center.

David A Lazica1, Stephan Roth, Alexander S Brandt, Stefanie Böttcher, Michael J Mathers, Burkhard Ubrig.   

Abstract

PURPOSE: We evaluated the results of second transurethral resections of the bladder (TURB) after pTa high-grade bladder cancer over a 4.5-year period. PATIENTS AND METHODS: From July 2007 to December 2011, 2,159 TURBs were performed at our institution, of which 1,143 were initial resections for primary bladder tumor or recurrence. Of these, 142 revealed pTa high-grade bladder cancer, and here we investigated tumor characteristics of initial TURB and results of second resection.
RESULTS: The incidence of pTa high-grade tumor was 12.4% (n = 142). Of 87 patients who underwent a second resection, tumor was found in 36 (41.4%); tumors were multifocal in 25 (69.4%) and <3 cm in 29 (80.6%). Tumor was detected at the primary site in 38.9%, at other locations in 22.2%, and at both in 38.9%. Histology revealed pTa low-grade in 13 (14.9% of 87), pTa high-grade in 15 (17.2%), and pT1 in 5 (5.7%) patients. No muscle-invasive tumor was detected. A significant association was found for the number of tumors at initial TURB: in patients with tumor at second resection, 55.1% had had multiple tumors at first resection, more than twice those with solitary tumor (23.7%) (0.004).
CONCLUSIONS: In our study, Ta high-grade tumors show a relevant rate of persistent tumor at second resection, most of them located at the primary tumor site. As recommended by the American and European clinical guidelines, patients with Ta high-grade tumor should undergo second resection. 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23988813     DOI: 10.1159/000353089

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  10 in total

1.  Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.

Authors:  Naoto Kamiya; Hiroyoshi Suzuki; Takahito Suyama; Masayuki Kobayashi; Satoshi Fukasawa; Nobuyuki Sekita; Kazuo Mikami; Naoki Nihei; Yukio Naya; Tomohiko Ichikawa
Journal:  Int J Clin Oncol       Date:  2016-10-15       Impact factor: 3.402

Review 2.  Guideline of guidelines: non-muscle-invasive bladder cancer.

Authors:  Solomon L Woldu; Aditya Bagrodia; Yair Lotan
Journal:  BJU Int       Date:  2017-01-24       Impact factor: 5.588

3.  Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database.

Authors:  Kaiwen Li; Tianxin Lin; Wei Xue; Xin Mu; Enci Xu; Xu Yang; Fubao Chen; Guangyong Li; Lulin Ma; Guoliang Wang; Chaozhao Liang; Haoqiang Shi; Ming Li; Mao Tang; Xueyi Xue; Yisong Lv; Yaoliang Deng; Chengyang Li; Zhiwen Chen; Xiaozhou Zhou; Fengshuo Jin; Xudong Liu; Jinxin Wei; Lei Shi; Xin Gou; Weiyang He; Liqun Zhou; Lin Cai; Baiye Jin; Guanghou Fu; Xiangbo Kong; Hongyan Sun; Ye Tian; Lang Feng; Tiejun Pan; Yiyi Wu; Dongwen Wang; Hailong Hao; Benkang Shi; Yaofeng Zhu; Qiang Wei; Ping Han; Changli Wu; Dawei Tian; Zhangqun Ye; Zheng Liu; Zhiping Wang; Junqiang Tian; Lin Qi; Minfeng Chen; Wei Li; Jinchun Qi; Gongxian Wang; Longlong Fu; Zhaolin Sun; Guangheng Luo; Zhoujun Shen; Zhaowei Zhu; Jinchun Xing; Zhun Wu; Dong Wei; Xin Chen; Yanqun Na; Hongfeng Guo; Chunxi Wang; Zhihua Lu; Chuize Kong; Yang Liu; Jin Yang; Jianyun Hu; Xin Gao; Jielin Li; Changjun Yin; Pu Li; Shan Chen; Zhen Du; Jiongming Li; Yongji Yan; Xu Zhang; Shuang Huang; Fangjian Zhou; Zhiling Zhang; Yinghao Sun; Shuxiong Zeng; Song Cen; Jiaquan Zhou; Hanzhong Li; Jin Wen; Jian Huang
Journal:  Asian J Urol       Date:  2015-04-16

4.  Value of separate tumor base biopsy in transurethral resection of bladder tumors.

Authors:  Ben Valery Sionov; Matvey Tsivian; Tarek Taha; Roman Bass; Alexander Kheifets; Abraham Ami Sidi; Alexander Tsivian
Journal:  Cent European J Urol       Date:  2020-11-06

5.  Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.

Authors:  Kyeongchae Lee; Seung-Hwan Jeong; Sang-Hyun Yoo; Ja Hyeon Ku
Journal:  Investig Clin Urol       Date:  2022-01

Review 6.  Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis.

Authors:  Jiangnan Xu; Zhenyu Xu; HuMin Yin; Jin Zang
Journal:  Front Surg       Date:  2022-09-14

Review 7.  Advances in risk stratification of bladder cancer to guide personalized medicine.

Authors:  Justin T Matulay; Ashish M Kamat
Journal:  F1000Res       Date:  2018-07-25

8.  Is there a role for second transurethral resection in pTa high-grade urothelial bladder cancer?

Authors:  Anuj Deep Dangi; Ramani Manoj Kumar; Thomas Alex Kodiatte; Mahasampth Gowri; Santosh Kumar; Antony Devasia; Nitin Kekre
Journal:  Cent European J Urol       Date:  2018-06-12

9.  Utility of restage transurethral resection of bladder tumor.

Authors:  Vignesh Manoharan; Ravimohan Suryanarayan Mavuduru; Santosh Kumar; Nandita Kakkar; Sudheer Kumar Devana; Girdhar Singh Bora; Shrawan Kumar Singh; Arup Kumar Mandal
Journal:  Indian J Urol       Date:  2018 Oct-Dec

10.  Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients.

Authors:  Wenhao Zhou; Wei Wang; Wenbo Wu; Tingmang Yan; Guofang Du; Haitao Liu
Journal:  BMC Urol       Date:  2020-03-18       Impact factor: 2.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.